RIL
BHVN

Rothschild Investment LLC’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Rothschild Investment LLC’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,500
Closed -$378K – 501
2022
Q3 		$378K Sell
2,500
-3,900
-61% -$578K 0.04% 320
2022
Q2 		$933K Sell
6,400
-3,800
-37% -$485K 0.09% 221
2022
Q1 		$1.21M Sell
10,200
-150
-1% -$18.7K 0.1% 200
2021
Q4 		$1.43M Sell
10,350
-200
-2% -$25.4K 0.11% 178
2021
Q3 		$1.47M Sell
10,550
-1,250
-11% -$156K 0.12% 166
2021
Q2 		$1.15M Buy
11,800
+2,200
+23% +$179K 0.09% 208
2021
Q1 		$656K Buy
9,600
+4,500
+88% +$364K 0.06% 267
2020
Q4 		$437K Buy
+5,100
New +$432K 0.04% 308
2020
Q3 		– Sell
-2,800
Closed -$205K – 464
2020
Q2 		$205K Buy
+2,800
New +$149K 0.02% 381

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Rothschild Investment LLC's BHVN Position: Q4 2022 in Review

Rothschild Investment LLC sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 2,500 shares — an estimated $378K sold.

Rothschild Investment LLC first reported a position in BHVN in Q2 2020 and held it in 9 quarters. The position peaked at $1.47M in Q3 2021. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Rothschild Investment LLC reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Rothschild Investment LLC sold 2,500 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $378K.
  • Rothschild Investment LLC first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2020 and held it in 9 quarters.
  • Rothschild Investment LLC's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $1.47M in Q3 2021.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Rothschild Investment LLC's 13F filing for Q4 2022, filed 19 Jan 2023.